Melanie Galla

3.5k total citations
48 papers, 2.5k citations indexed

About

Melanie Galla is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Melanie Galla has authored 48 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 25 papers in Genetics and 11 papers in Immunology. Recurrent topics in Melanie Galla's work include Virus-based gene therapy research (24 papers), CRISPR and Genetic Engineering (23 papers) and RNA Interference and Gene Delivery (18 papers). Melanie Galla is often cited by papers focused on Virus-based gene therapy research (24 papers), CRISPR and Genetic Engineering (23 papers) and RNA Interference and Gene Delivery (18 papers). Melanie Galla collaborates with scholars based in Germany, United States and United Kingdom. Melanie Galla's co-authors include Axel Schambach, Christopher Baum, Tobias Maetzig, Rainer Loew, Johannes Kuehle, Michael Morgan, Martijn H. Brugman, Katharina Zimmermann, Christopher Baum and Elmar Jaeckel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Melanie Galla

48 papers receiving 2.4k citations

Peers

Melanie Galla

GENET

ONCOL

IMMUN

Carole Masurier France

Steven J. Howe United Kingdom

Minh Nguyen United States

Ali Nowrouzi Germany

Tobias Maetzig Germany

Ute Modlich Germany

Pietro Genovese United States

Daniela Cesana Italy

Cynthia C. Bartholomae Germany

Si–Yi Chen United States

Carole Masurier France

Melanie Galla

2.0k ×1.2

978 ×0.9

GENET

501 ×0.7

ONCOL

807 ×1.6

IMMUN

159 ×1.1

Citations per year, relative to Melanie Galla Melanie Galla (= 1×) peers Carole Masurier

Countries citing papers authored by Melanie Galla

Since Specialization

Citations

This map shows the geographic impact of Melanie Galla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Galla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Galla more than expected).

Fields of papers citing papers by Melanie Galla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Galla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Galla. The network helps show where Melanie Galla may publish in the future.

Co-authorship network of co-authors of Melanie Galla

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Galla. A scholar is included among the top collaborators of Melanie Galla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Galla. Melanie Galla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schott, Juliane W., et al.. (2024). The caspase-inhibitor Emricasan efficiently counteracts cisplatin- and neomycin-induced cytotoxicity in cochlear cells. Journal of Molecular Medicine. 102(9). 1163–1174. 3 indexed citations

Hardtke‐Wolenski, Matthias, Danny Jonigk, Melanie Galla, et al.. (2024). Graft-Specific Regulatory T Cells for Long-Lasting, Local Tolerance Induction. Cells. 13(14). 1216–1216. 2 indexed citations

Selich, Anton, Melanie Galla, Constantin von Kaisenberg, et al.. (2023). Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs. Stem Cell Research & Therapy. 14(1). 270–270. 4 indexed citations

Klatt, Denise, Dirk Hoffmann, Julia D. Suerth, et al.. (2022). Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells. Molecular Therapy — Nucleic Acids. 27. 810–823. 13 indexed citations

Yu, Kai, Swantje I. Hammerschmidt, Marc Permanyer, et al.. (2021). Targeted delivery of regulatory macrophages to lymph nodes interferes with T cell priming by preventing the formation of stable immune synapses. Cell Reports. 35(12). 109273–109273. 4 indexed citations

Permanyer, Marc, Kathrin Werth, Kai Yu, et al.. (2020). Efficient homing of T cells via afferent lymphatics requires mechanical arrest and integrin-supported chemokine guidance. Nature Communications. 11(1). 1114–1114. 41 indexed citations

Bošnjak, Berislav, Marc Permanyer, Maya K. Sethi, et al.. (2018). CRISPR/Cas9 Genome Editing Using Gold‐Nanoparticle‐Mediated Laserporation. Advanced Biosystems. 2(11). 19 indexed citations

Hammerschmidt, Swantje I., Kathrin Werth, Michael Rothe, et al.. (2018). CRISPR/Cas9 Immunoengineering of Hoxb8-Immortalized Progenitor Cells for Revealing CCR7-Mediated Dendritic Cell Signaling and Migration Mechanisms in vivo. Frontiers in Immunology. 9. 1949–1949. 25 indexed citations

Eggenschwiler, Reto, Melanie Galla, Maximilian Naujock, et al.. (2016). Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase. Scientific Reports. 6(1). 38198–38198. 23 indexed citations

10.

Menon, M., Akihiro Sawada, Anuhar Chaturvedi, et al.. (2014). Genetic Deletion of SEPT7 Reveals a Cell Type-Specific Role of Septins in Microtubule Destabilization for the Completion of Cytokinesis. PLoS Genetics. 10(8). e1004558–e1004558. 77 indexed citations

11.

Bobis‐Wozowicz, Sylwia, Melanie Galla, Jamal Alzubi, et al.. (2014). Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery. Scientific Reports. 4(1). 4656–4656. 23 indexed citations

12.

Maetzig, Tobias, Martijn H. Brugman, Stefan Bartels, et al.. (2011). Polyclonal fluctuation of lentiviral vector–transduced and expanded murine hematopoietic stem cells. Blood. 117(11). 3053–3064. 46 indexed citations

13.

Turan, Soeren, Melanie Galla, Junhua Qiao, et al.. (2011). Recombinase-Mediated Cassette Exchange (RMCE): Traditional Concepts and Current Challenges. Journal of Molecular Biology. 407(2). 193–221. 127 indexed citations

14.

Kuehle, Johannes, Tobias Cantz, Martijn H. Brugman, et al.. (2011). Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming. Molecular Therapy. 19(4). 782–789. 206 indexed citations

15.

Galla, Melanie, Axel Schambach, Christine S. Falk, et al.. (2011). Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Research. 39(16). 7147–7160. 53 indexed citations

16.

Heinz, Niels, Axel Schambach, Melanie Galla, et al.. (2010). Retroviral and Transposon-Based Tet-Regulated All-In-One Vectors with Reduced Background Expression and Improved Dynamic Range. Human Gene Therapy. 22(2). 166–176. 74 indexed citations

17.

Maetzig, Tobias, Melanie Galla, Martijn H. Brugman, et al.. (2009). Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors. Gene Therapy. 17(3). 400–411. 38 indexed citations

18.

Schambach, Axel, Melanie Galla, Ute Modlich, et al.. (2006). Lentiviral vectors pseudotyped with murine ecotropic envelope: Increased biosafety and convenience in preclinical research. Experimental Hematology. 34(5). 588–592. 90 indexed citations

19.

Baum, Christopher, Axel Schambach, Jens Bohne, & Melanie Galla. (2006). Retrovirus Vectors: Toward the Plentivirus?. Molecular Therapy. 13(6). 1050–1063. 66 indexed citations

20.

Galla, Melanie, Elke Will, Janine Kraunus, Lei Chen, & Christopher Baum. (2004). Retroviral Pseudotransduction for Targeted Cell Manipulation. Molecular Cell. 16(2). 309–315. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact